Liver Fibrosis
174
26
28
80
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
16 trials with published results (9%)
Research Maturity
80 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.6%
8 terminated out of 174 trials
90.9%
+4.4% vs benchmark
10%
18 trials in Phase 3/4
20%
16 of 80 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 80 completed trials
Clinical Trials (174)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis: an RCT
Isocaloric Navy-Bean Substitution in Adults With MASLD
Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response
Fibrosis Lessens After Metabolic Surgery
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.
Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness
Early Liver Disease Breath Detection
A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.
Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
Patients With Primary Biliary Cholangitis(PBC)
Incidence of Liver Disease-Related Outcomes in People With HIV
Interventional AI-Human Collaboration for Steatotic Liver Disease Screening
Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease
Sonazoid CEUS for Early HCC Surveillance
Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity